Blog

Solving humanity’s greatest challenges requires bold, visionary researchers who look beyond the traditional confines of science and medicine to create new possibilities. Karen Toffler Charitable Trust fuels the work of these pioneers through our future-focused framework — one that hinges on early-stage research, high-impact ideas, and cross-disciplinary problem-solving. Due to the nascent stages of their…

The Karen Toffler Charitable Trust (KTCT) is supporting cutting-edge scientists like Dr. LaVoie to explore the uncharted territory of high-risk research. With their funding, Dr. LaVoie has uncovered an exciting new avenue of research that could revolutionize the way we approach Lewy Body Dementia. When Dr. LaVoie was awarded a Grant from the Karen Toffler…

The global research and development (R&D) ecosystem is changing rapidly and dramatically. An arena once dominated, fueled, and funded by U.S. federal government organizations like the National Science Foundation, NIH, NASA, Office of Naval Research, and the Defense Advanced Research Projects Agency (DARPA) is now being driven — and bankrolled — by investors from industry,…

Toffler Scholar Adithya Gopinath’s research explores the connection between the brain and the peripheral immune system in people with Parkinson’s disease with the goal of developing a blood test to diagnose and monitor the disease and evaluate whether treatments are working. Learn more about his research in this article from University of Florida.

About 46.8 million people worldwide were living with dementia in 2015, and this number could double by 2035. Reliably differentiating between normal cognitive aging, mild cognitive impairment, and dementia requires significant clinical acumen from qualified specialists treating memory disorders, yet timely access to memory clinics is often limited for patients and families. Boston University Toffler…

UCLA Toffler Scholar Dr. Elizabeth Rose Mayeda was part of the team that presented research that begins to give us insight into why Alzheimer’s disease affects more women than men and why the disease seems to progress more quickly in women’s brains. Learn more about her research in this article from NPR.